Cherenkov radiation has emerged as a novel source of light with a number of applications in the biomedical sciences. It's unique properties, including its broadband emission spectrum, spectral weighting in the ultraviolet and blue wavebands, and local generation of light within a given tissue have made it an attractive source of light for techniques ranging from widefield imaging to oximetry and phototherapy. To help guide the future development of this field in the context of molecular imaging, quantitative estimates of the light fluence rates of Cherenkov radiation from a number of radionuclide and external radiotherapy beams in tissue was explored for the first time. Using Monte Carlo simulations, these values were found to be on the order of 0.1 -1 nW/cm 2 per MBq/g for radionuclides and 1 -10 μW/cm 2 per Gy/sec for external radiotherapy beams, dependent on the given waveband and optical properties. For phototherapy applications, the total light fluence was found to be on the order of nJ/cm 2 for radionuclides, and mJ/cm 2 for radiotherapy beams. To validate these findings, experimental validation was completed with an MV x-ray photon beam incident onto a tissue phantom, confirming the magnitudes of the simulation values. The results indicate that diagnostic potential is reasonable for Cherenkov excitation of molecular probes, but phototherapy may remain elusive at these relatively low fluence values.
INTRODUCTION
In recent years there has been a growing interest in biophotonic applications of Cherenkov radiation, a form of light emission that occurs when a charged particle exceeds the local speed of light in a dielectric medium 1 . To date, these applications have included small animal imaging of radionuclide distributions and kinetics [2] [3] [4] [5] [6] , clinical imaging of 18 F-FDG in human patients 7, 8 , as well as dosimetric imaging during external beam radiation therapy [9] [10] [11] [12] [13] [14] [15] [16] . While all of these studies have appreciated the inherently weak intensity of this form of light emission, there have been limited attempts at absolute quantification of the light fluence of Cherenkov radiation for each of these applications. Simple experimental measurements have suggested that the light fluence from radiotherapy beams is on the order of [nW/cm 2 ], and no light fluence measurements have been reported for radionuclides in mammalian tissue 17, 18 . One previous study explored the light production of a number of radionuclides in [photons/disintegration], but the subsequent optical light transport was not considered, an important additional step in estimating the light fluence for biomedical applications 19 . Estimates of this quantity would be particularly important in guiding the development of future imaging systems and biophotonics applications utilizing Cherenkov radiation, particularly with the emerging interest in using Cherenkov radiation for low fluence threshold phototherapy [20] [21] [22] [23] . Herein we develop a methodology for quantifying the light fluence of Cherenkov radiation and provide estimates for a number of relevant radionuclides and radiotherapy beams using a recently developed and validated Monte Carlo package for the simulation of radiation-induced light transport in biological media 24 .
METHODS

Simulation method
Monte Carlo simulations were run using the Geant4 Architecture for Medically-oriented Simulations (GAMOS) tissueoptics plugin [24] [25] [26] . In the case of radionuclides, decays were modeled using the radioactive decay physics process, which properly models all statistically disintegrations specific to each radionuclide. In total, ten radionuclides were modeled, including 225 Ac, For all simulations the anisotropy was fixed at an average cosine value, g = 0.9, to estimate what the reduced scattering coefficient, , would be. In the case of radiotherapy beams, x-ray photon and electron beams were modeled using Varian proprietary phase space files (available at myvarian.com). Although these phase space files are recorded above the jaws, the spectrum of all particles was calculated and then used as the input spectrum for a pencil beam incident on a soft tissue volume of refractive index n = 1.37. For x-ray photons, beam energies of 4, 6, 8, 10, and 15 MV were modeled, and for electrons beam energies of 6, 9, 12, 15, and 18 MeV were modeled. The light fluence due to the pencil beams was recorded in cylindrical coordinates at radial positions of 0 -2 cm in 0.1 mm increments from the origin, and depths of 0 -10 cm in 0.1 mm increments from the tissue surface. The Green's function for light fluence, ( , , , ) [photons/cm 2 /particle], normalized per incident particle, was simulated as a function of the same optical scattering, absorption, and anisotropy as for the radionuclides. In addition, the Green's function for dose deposition, ( , ) [Gy/particle], was recorded. The dose deposition, ( ) [Gy/particle], was also recorded for 90 Y. Note that the Green's functions for dose deposition are independent of optical properties. Representative geometries for both simulations are shown in Figure 1 . Figure 1 . In (a) the simulation geometry for the radionuclides is shown. All particle decays (purple) are initiated at the origin, and the fluence of the induced Cherenkov radiation (green) is recorded as a function or radius, r, in spherical shells. In (b) the simulation geometry for the radiotherapy beams is shown. All particles (blue) are initiated at the origin and downward along the z axis. The fluence of the induced Cherenkov radiation (green) is recorded as a function of radius, r, and depth, z.
Optical properties of a generic tissue
To model the spectral fluence of Cherenkov radiation in a generic tissue, the generated Green's functions for light fluence were interpolated using a parametric mapping optical properties to wavelength space. To generate biologically relevant scattering and absorption coefficients, a methodology analogous to Jacques et. al. was utilized 27 . The optical property ranges of a generic tissue are shown in Figure 2 . In (b) the optical absorption coefficient, μ a , is shown.
Calculating and fluence rate
The spectrally resolved Green's functions were then used to calculate the fluence and fluence rate by convolving the pencil beams over a 2D field size (chosen to be a circle with a 1 cm radius for this study), or a 3D spherical volume for radionuclide point sources (also with a radius of 1 cm for this study). The fluence and fluence rate were then calculated per nm by scaling the Cherenkov radiation by the inverse square with wavelength dependence described by the FrankTamm formula, and normalized either by the activity per unit mass for radionuclides, or dose rate per deposited dose in tissue for radiotherapy beams. The results for the calculated fluence rates of Cherenkov radiation for all radionuclides and radiotherapy beams are shown in Figure 3 , integrated over a broad waveband of 250 -850 nm. The fluence rates are presented both in the prescence (red bars) and absence of optical absorption (green bars).
RESULTS
DISCUSSION AND CONCLUSIONS
The results presented in this study aim to quantify the optical light fluence and fluence rate of Cherenkov radiation in biological media from a range of radionuclides and external radiotherapy beams. Due to the broadband white light nature of this light emission, optical properties of a generic breast tissue from a number of sources in the literature were evaluated. In the case of radionuclides, the fluence rate was calculated as a function of activity per unit mass [MBq/g] and in the case of external radiotherapy beams the fluence rate was calculated as a function of dose rate [Gy/sec]. In general, the fluence rate between 250 -850 nm from radionuclides was found to be on the order of 0.3 -30 fW/cm 2 /(MBq/g). Similarly, the fluence rate from external radiotherapy beams was found to be on the order of 300 -500 nW/cm 2 /(Gy/sec). An interesting characteristic of Cherenkov radiation is its local generation inside a medium, as opposed to delivery of light inside a biological medium from an external light source. In the latter case, light reaching a region of interest within a medium is diffuse and is therefore heavily attenuated by the optical absorption of the tissue, yet in the case of Cherenkov radiation, light may be generated inside a given cell and experience little optical absorption at the microscopic level. Therefore, light fluence rate estimates were also computed in the presence of optical scattering, but in the absence of optical absorption. In this case, the fluence rate of radionuclides was found to be on the order of 5 -500 fW/cm 2 /(MBq/g) and in the case of external radiotherapy beams on the order of 4000 -8000 nW/cm 2 /(Gy/sec). Therefore, in the absence of optical absorption the fluence rate of Cherenkov light emission from either radiation source is increased by ~ 1 -2 orders of magnitude, and the overall limits for the expected fluence rate is 0.3 -500 fW/cm 2 /(MBq/g) for radionuclides, or 300 -8000 nW/cm 2 /(Gy/sec). In the case of radionuclides, a strong variation in fluence rate exists between different radionuclides due to the different particle emission energies. For example, 90 Y, a high-energy β emitter results in fluence rate roughly ten times that of 11 C. When analyzed as a function of dose rate, the fluence rate from a 90 Y source is comparable to external radiotherapy beams. In general, the observed variation in fluence rate as a function of beam energy was minimal due to its normalization as a function of dose rate, i.e. the number of Cherenkov photons generated per unit dose for any radiotherapy beam does not change dramatically.
Molecular imaging of Cherenkov radiation
For molecular imaging applications, the fluence rate is the primary quantity of interest. In the case of radionuclides, the results of are presented per tissue activity concentration. This quantity is both organ and radionuclide dependent, but as an example, the myocardium tissue activity concentration of 18 F has been estimated to be in the range of 1 -10 MBq/g 28 . Under these conditions, the local fluence rate of Cherenkov radiation would be ~0.3 -300 fW/cm 2 in the presence of optical absorption or ~5 -5000 fW/cm 2 in the absence of optical absorption between 250 -850 nm. For radiotherapy beams, the dose rate is easily specified on a given treatment machine and can therefore used to calculate a fluence rate. For most modern linear accelerators, this ranges from 1 -10 Gy/min. Therefore, for a 6 MV x-ray photon beam, the local Cherenkov radiation fluence would be ~300 -5000 nW/cm 2 in the presence of optical absorption or ~300 -80000 nW/cm 2 in the absence of optical absorption between 250 -850 nm. Imaging of these optical signals is achievable by using highly sensitive cameras, or long exposure times. In the case of radionuclides, this weak signal requires exposure times on the order of minutes, whereas this signal from radiotherapy beams can be captured in near real-time 15 . So it is important to recognize that using these signals for molecular imaging is feasible, but typically would require some of the most sensitive measurements systems or cameras available.
Phototherapy with Cherenkov radiation
To calculate the total fluence delivered to tissue from a radionuclide, the fluence rate must be integrated in time, or more simply the total number of radioactive decays per unit volume must be known. Calculation of these quantities has been studied previously for applications in radiation dosimetry of PET scans using the MIRD system 29 . Once again using 18 F as an example, the number of decays in each organ has been reported to be on the order of 100 -10000 decays per injected Bq. Using a conservative estimate of an organ volume of 10 cm 3 , and a typical injected concentration of 370
MBq, the total fluence delivered within a representative organ would be ~3.5 -3500 nJ/cm 2 in the presence of optical absorption or ~ 50 -50000 nJ/cm 2 in the absence of optical absorption between 250 -850 nm. Given the similar Cherenkov radiation fluence rates calculated for the various radionuclides presented in this study, it seems unlikely that Cherenkov radiation from these radiation sources is a suitable source for phototherapy. One exception to the above is 90 Y, which may be used for Brachytherapy delivering doses on the order of 100 Gy. In this case, the total light fluence can be calculated and is ~0.03 -0.05 mJ/cm 2 in the presence of optical absorption and ~0.4 -0.8 mJ/cm 2 in the absence of optical absorption between 250 -850 nm. Given the similar fluence rates calculated for 90 Y with respect to the radiotherapy beams, it is expected that electron and x-ray photon beams may also deliver Cherenkov radiation fluences on the order of [mJ/cm 2 ] during external beam radiotherapy. Given the recent interest into low-light level phototherapy, these values may help in guiding the emerging applications using Cherenkov radiation as the light source [21] [22] [23] 30 . Taken as a whole, the light levels from imaging radionuclides (e.g. 18 F) are many orders of magnitude lower than reported threshold values for photodynamic action, while Cherenkov radiation fluence levels from external beams and 90 Y are on the order of [mJ/cm 2 ] which may potentially be, albeit a weak, excitation source for phototherapy. Therefore it is not obvious that Cherenkov could be used as an efficient means to activate a phototherapeutic effect in-vivo without some additional photochemistry (e.g., radiosensitization) also contributing to the process.
